Vitro Biopharma, Inc. Quarterly Operating Lease, Liability, Noncurrent in USD from Q3 2022 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.
Summary
Vitro Biopharma, Inc. quarterly Operating Lease, Liability, Noncurrent history and growth rate from Q3 2022 to Q2 2024.
  • Vitro Biopharma, Inc. Operating Lease, Liability, Noncurrent for the quarter ending July 31, 2024 was $256K, a 33.6% decline year-over-year.
Operating Lease, Liability, Noncurrent, Quarterly (USD)
Operating Lease, Liability, Noncurrent, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $256K -$129K -33.6% Jul 31, 2024 10-Q 2024-09-16
Q1 2024 $285K +$80.9K +39.6% Apr 30, 2024 10-Q 2024-05-31
Q4 2023 $315K +$99.6K +46.2% Jan 31, 2024 10-Q 2024-03-14
Q3 2023 $346K +$119K +52.2% Oct 31, 2023 10-Q 2024-09-16
Q2 2023 $385K Jul 31, 2023 10-Q 2023-08-28
Q1 2023 $204K Apr 30, 2023 10-Q 2023-06-13
Q4 2022 $216K Jan 31, 2023 10-Q 2023-03-14
Q3 2022 $227K Oct 31, 2022 10-K 2024-01-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.